ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   


By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile

 

Pharming Group N.V. 

P.O. Box 451

AL Leiden    2300  The Netherlands
Phone: 31-0-71-524-7400 Fax: +31-0-71-521-6507


SEARCH JOBS








 Company News
Pharming Group (PHGUF.PK) Reports On Preliminary Financial Results 2013 3/6/2014 9:04:51 AM    More...
Salix Pharmaceuticals, Ltd. (SLXP), Pharming Group (PHGUF.PK) Announce Extension Of PDUFA Action Date For RUCONEST® 2/24/2014 6:44:49 AM    More...
Pharming Group (PHGUF.PK) and Santarus Inc. (SNTS) Announce New Data From Open-Label Repeat Treatment Study With Rucomest 11/8/2013 9:08:34 AM    More...
Santarus Inc. (SNTS) and Pharming Group (PHGUF.PK) Announce New Data From Open-Label Repeat Treatment Study With RUCONEST (Recombinant Human C1 Esterase Inhibitor) 11/8/2013 7:51:26 AM    More...
Pharming Group (PHGUF.PK) Reports on Financial Results for the First Nine Months of 2013 11/7/2013 9:26:44 AM    More...
Pharming Group (PHGUF.PK) Announces €12.0 Million Private Equity Placement With Institutional Investors 10/9/2013 6:44:51 AM    More...
Pharming Group (PHGUF.PK) Redeems Final Tranche of Convertible Bond for Cash 8/29/2013 9:44:04 AM    More...
Pharming Group (PHGUF.PK) Reports on Financial Results First Half Year 2013 8/1/2013 8:08:11 AM    More...
Santarus Inc. (SNTS) and Pharming Group (PHGUF.PK) Announce Poster Presentation of Pivotal Clinical Data for RUCONEST (Recombinant Human C1 Esterase Inhibitor) 6/25/2013 11:12:30 AM    More...
Pharming Group (PHGUF.PK) Elects to Redeem Fifth Tranche of Convertible Bond for Cash 6/24/2013 10:26:37 AM    More...
12345678910...